• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GTG
Click for more information
0.00% 12.0¢

GENETIC TECHNOLOGIES LIMITED - Charts / Financials

Market Cap $15.86M  ! watchlist Created with Sketch. Add to my watchlist
Technology Scientific & Technical Instruments

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics... Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company operates through three segments: EasyDNA, AffinityDNA, and GeneType / Corporate. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and morMore

refresh Created with Sketch. REFRESH
Last update - 16.20pm 03/05/2024 (20 minute delay) ?
Day
Open 12.0¢   Day High 12.0¢   Day Low 11.0¢
Daily Volume 36833
Bids   Sellers
Number Price Volume   Number Price Volume
1 11.0¢ 17530   2 12.0¢ 4879

Directors & Senior Management

Mr. Simon Morriss Chief Executive Officer
Ms. Kathryn Andrews Chief Financial Officer, Company Secretary
Mr. Kevin Camilleri Chief Executive Officer - EasyDNA
Dr. Richard Allman Chief Scientific Officer
Mr. Carl Stubbings Chief Commercial Officer
Mr. Peter Irwin Rubinstein Non-Executive Independent Chairman of the Board
Dr. Jerzy Muchnicki Non-Independent Non-Executive Director
Dr. Lindsay Peter Wakefield Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
12.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $15.86M
Open High Low Value Volume
12.0¢ 12.0¢ 11.0¢ $4.415K 36.83K

Buyers (Bids)

No. Vol. Price($)
1 17530 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 4879 2
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?

Top Stories

Infini Resources gearing up for UAV geophys survey over Portland Creek

Infini Resources has announced its execution of an application for UAV-based geophysical surveys over its Portland Creek Uranium Project.
Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Patagonia shares rise above 20% on lithium grades at maiden well in Argentina Patagonia Lithium shares rise above 12 percent on lithium grading nearly 600 parts per million at the first drill well of its Argentinian Formentera Lithium Project.
Provident Aurum's off-market bid sends Sihayo shares soaring Small-cap mineral and gold explorer, Sihayo Gold (ASX:SIH) shares have soared, on news that the company has received intentions from Provident Aurum Pte to make an off-market takeover offer to acquire all shares of Sihayo Gold.
Macquarie profits fall 32% on 'market volatility' and low-achieving 'green investments' Macquarie Group Ltd (ASX:MQG) has shaved more than 30 percent off its net profit in the final quarter of the 2024 financial year (FY 2024), compared to the same time last year, with executives speaking cautiously about market volatility and @lower asset realisations’ from green in...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.